Favorable effects on metabolic risk factors with daily brewer’s yeast in type 2 diabetic patients with hypercholesterolemia: A semi‐experimental study
Open Access
- 20 October 2011
- journal article
- research article
- Published by Wiley in Journal of Diabetes
- Vol. 4 (2) , 153-158
Abstract
Background: The aim of the present study was to investigate the effect of brewer’s yeast on plasma glucose and lipid profiles in patients with type 2 diabetes (T2D).Methods: The present semi‐experimental study was performed on 55 T2D patients with hypercholesterolemia. All patients received 12 tablets of 300 mg yeast per day for 8 weeks. Each tablet contained 1.2 μg chromium. Fasting plasma glucose, total cholesterol, high‐density lipoprotein–cholesterol (HDL–C), low‐density lipoprotein–cholesterol (LDL–C), and triglyceride levels were measured at baseline and then again at Weeks 4 and 8.Results: Although there was a tendency for plasma glucose levels to decrease at Week 4, the difference failed to reach statistical significance (P = 0.065). However, after 8 weeks, the decrease in plasma glucose was significant (P = 0.043). Again, although there was a tendency for decreased plasma cholesterol at Week 8 compared with baseline, the difference failed to reach statistical significance (215 ± 29 vs 226 ± 37 mg/dL, respectively; P = 0.056). Brewer’s yeast significantly decreased plasma triglyceride and LDL–C levels at Weeks 4 and 8. In contrast, plasma HDL–C levels were significantly increased at both 4 and 8 weeks compared with baseline (41.3 ± 8.8 and 43.3 ± 7.5 vs 36 ± 5 mg/dL, respectively; P < 0.01 and P < 0.01, respectively).Conclusion: In conclusion, the consumption of brewer’s yeast over a period of 8 weeks may improve cardiometabolic risk factors in T2D patients. However, these findings need to be confirmed in a large double‐blind clinical trial.Keywords
This publication has 25 references indexed in Scilit:
- The Dietary Approaches to Stop Hypertension Eating Plan Affects C-Reactive Protein, Coagulation Abnormalities, and Hepatic Function Tests among Type 2 Diabetic PatientsThe Journal of Nutrition, 2011
- Effects of the Dietary Approaches to Stop Hypertension (DASH) Eating Plan on Cardiovascular Risks Among Type 2 Diabetic PatientsDiabetes Care, 2010
- Effect of Chromium Supplementation on Glucose Metabolism and LipidsDiabetes Care, 2007
- Chromium Treatment Has No Effect in Patients With Type 2 Diabetes in a Western PopulationDiabetes Care, 2007
- Anti-Diabetic Activity and Mechanism of Action of Chromium ChlorideExperimental and Clinical Endocrinology & Diabetes, 2004
- Beneficial Effects of Chromium in People with Type 2 Diabetes, and Urinary Chromium Response to Glucose Load as a Possible Indicator of StatusBiological Trace Element Research, 2002
- The effects of chromium supplementation on serum glucose and lipids in patients with and without non-insulin-dependent diabetesMetabolism, 1992
- Effect of high-chromium brewer's yeast on human serum lipids.Journal of the American College of Nutrition, 1982
- Chromium in foods in relation to biological activityJournal of Agricultural and Food Chemistry, 1973
- Effect of trivalent chromium on glucose toleranceMetabolism, 1966